Irreversible chronic vascular rejection occurs only after development of advanced allograft vasculopathy: A comparative study of a rat cardiac allograft model using a retransplantation protocol

Transplantation

Volumn 63, Issue 5, 1997, Pages 743-749

  Forbes, R D Clarke ^a   Zheng, Shu Xin ^a   Gomersall, Margaret ^a   Guttmann, Ronald D ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HEART GRAFT; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOPATHOLOGY; ISOGRAFT; NONHUMAN; PRIORITY JOURNAL; RAT; STRAIN DIFFERENCE;

EID: 0030974982     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199703150-00022     Document Type: Article

References (26)

1. Adams DH, Tilney NL. The pathobiology of chronic rejection. Transplant Rev 1989; 3: 131.
2. Tullius SG, Tilney NL. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 1995; 59: 313.
3. Tilney NL, Whitley WD, Diamond JR, et al. Chronic rejection - an undefined conundrum. Transplantation 1991; 52: 389.
4. Russell PS, Chase CM, Winn HJ, et al. Coronary atherosclerosis in transplanted mouse hearts: II. Importance of humoral immunity. Immunology 1994; 152: 5135.
5. Cramer DV, Chapman FA, Wu G-D, et al. Cardiac transplantation in the rat: II. Alteration of the severity of donor graft arteriosclerosis by modulation of the host immune response. Transplantation 1990; 50: 554.
6. Guttmann RD, Forbes RDC, Zheng S, et al. Cyclosporine and the reversibility of chronic vascular rejection. Transplant Proc 1994; 26: 2564.
7. Handa N, Hatanaka M, Baumgartner WA, et al. Late cyclosporine treatment ameliorates established coronary graft disease in rat allografts. Transplantation 1993; 56: 535.
8. Meiser B, Reichart B. Graft vessel disease: the impact of immunosuppression and possible treatment strategies. Immunol Rev 1993; 134: 99.
9. Mennander A, Tiisala S, Paavonen T, et al. Chronic rejection of rat aortic allograft: II. Administration of cyclosporine induces accelerated allograft arteriosclerosis. Transpl Int 1991; 4: 173.
10. Tullius SG, Hancock WW, Heemann V, et al. Reversibility of chronic renal allograft rejection. Transplantation 1994; 58: 93.
11. Izutani H, Miyagawa S, Shirakura R, et al. Evidence that graft coronary arteriosclerosis begins in the early phase after transplantation and progresses without chronic immunoregulation. Transplantation 1995; 60: 1073.
12. Forbes RDC, Gomersall M, Guttmann RD. Chronic vascular rejection in an inbred rat cardiac model. Transplant Proc 1991; 23: 613.
13. + T cell depletion does not alter development of chronic vascular rejection in a rat cardiac allograft model. Transplantation 1994; 57: 1238.
14. Forbes RDC, Chernacek P, Zheng S-X, et al. Increased endothelin expression in a rat cardiac allograft model of chronic vascular rejection. Transplantation 1996; 61: 791.
15. Ono K, Lindsay ES. Improved technique of heart transplant in rats. J Thorac Cardiovasc Surg 1969; 57: 525.
16. Forbes RDC, Guttmann RD. Pathogenetic studies of cardiac allograft rejection using inbred rat models. Immunol Rev 1984; 77: 5.
17. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801.
18. Kupiec-Weglinski JW, Araujo JL, Towpike E, et al. Host-graft relationship: the systemic nature of allograft rejection. Surgery 1985; 98: 259.
19. Watschinger B, Sayegh MH, Hancock WW, et al. Upregulation of endothelin-1 mRNA and peptide expression in rat cardiac allografts with rejection and arteriosclerosis. Am J Pathol 1995; 146: 1065.
20. Paul LC, Davidoff A, Benediktsson H. Efficacy of cyclosporine and angiotensin-converting enzyme inhibitor to inhibit cardiac graft atherosclerosis in the rat. Transplant Proc 1994; 26: 2873.
21. Korecky B, Masika M. Direct effect of increased hemodynamic load on cardiac mass. Circ Res 1991; 68: 1174.
22. Clinton SK, Libby P. Cytokines and growth factors in athorogenesis. Arch Pathol Lab Med 1992; 116: 1292.
23. Guarda E, Katwa LC, Myers PR, et al. Effects of endothelins on collagen turnover in cardiac fibroblasts. Cardiovasc Res 1993; 27: 2130.
24. Tullius SG, Heemann U, Azuma H, et al. Early ischemic injury leads to long-term functional and morphologic deterioration of naive rat kidneys and may contribute to changes of chronic allograft rejection. Transplant Proc 1994; 26: 2041.
25. Tanaka H, Sukhova GK, Libby P. Interaction of the allogeneic state and hypercholesterolemia in arterial lesion formation in experimental cardiac allografts. Arterioscler Thromb 1994; 14: 734.
26. McCaffrey TA, Nicholson AC, Szabo PE, et al. Aging and atherosclerosis: the increased proliferation of arterial smooth muscle cells isolated from old rats is associated with increased platelet-derived growth factor activity. J Exp Med 1988; 167: 163.